Related Experiment Videos
Bacterial persistence in leprosy
Abstract:
Bacterial persistence is the capability of microorganisms to survive in the host despite adequate antimicrobial treatment. This is a general phenomenon and has been observed during infection with a number of organisms. The subject is reviewed in relation to the treatment of leprosy. The presence of persisters in the large bacterial populations that exist in patients with lepromatous leprosy is not surprising. It is unlikely that in the near future a new drug or combination of drugs will be found that is capable of eradicating persisting M. leprae. It may be useful, nevertheless, to reconsider whether the sporadic demonstration of viable, drug-susceptible organisms after antimicrobial treatment of variable duration and efficacy warrants a policy of life long chemotherapy in lepromatous leprosy.
Insights
Bacterial persistence allows microbes to survive treatment. In lepromatous leprosy, eradicating persisting Mycobacterium leprae is challenging, questioning the need for lifelong chemotherapy.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Therapy
Background:
- Bacterial persistence is a phenomenon where microorganisms survive host antimicrobial treatment.
- This survival capability is observed across various infections.
- The review focuses on bacterial persistence in the context of leprosy treatment.
Purpose of the Study:
- To review bacterial persistence in relation to leprosy treatment.
- To discuss the implications of persisting Mycobacterium leprae in lepromatous leprosy.
- To evaluate the necessity of lifelong chemotherapy for lepromatous leprosy.
Main Methods:
- Literature review on bacterial persistence.
- Analysis of M. leprae survival during antimicrobial treatment.
- Discussion of clinical implications for leprosy management.
Main Results:
- The presence of persisters in large bacterial populations in lepromatous leprosy is expected.
- Eradication of persisting M. leprae with current or near-future drugs is unlikely.
- Sporadic detection of viable, drug-susceptible organisms challenges current treatment policies.
Conclusions:
- Lifelong chemotherapy for lepromatous leprosy may need re-evaluation.
- The presence of persisters does not automatically justify indefinite treatment.
- Further consideration of treatment duration based on evidence of persisters is warranted.